Apellis Pharmaceuticals, Inc. Quarterly Other Liabilities, Noncurrent in USD from Q4 2018 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.
Summary
Apellis Pharmaceuticals, Inc. quarterly Other Liabilities, Noncurrent history and growth rate from Q4 2018 to Q2 2024.
  • Apellis Pharmaceuticals, Inc. Other Liabilities, Noncurrent for the quarter ending June 30, 2024 was $2.69M, a 527% increase year-over-year.
Other Liabilities, Noncurrent, Quarterly (USD)
Other Liabilities, Noncurrent, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 $2.69M +$2.26M +527% Jun 30, 2024 10-Q 2024-08-01
Q1 2024 $2.66M +$2.31M +666% Mar 31, 2024 10-Q 2024-05-07
Q4 2023 $2.31M Dec 31, 2023 10-Q 2024-08-01
Q3 2023 $946K -$992K -51.2% Sep 30, 2023 10-Q 2023-11-01
Q2 2023 $429K -$1.14M -72.7% Jun 30, 2023 10-Q 2023-07-31
Q1 2023 $347K -$861K -71.3% Mar 31, 2023 10-Q 2023-05-04
Q3 2022 $1.94M Sep 30, 2022 10-Q 2022-11-07
Q2 2022 $1.57M Jun 30, 2022 10-Q 2022-08-08
Q1 2022 $1.21M Mar 31, 2022 10-Q 2022-05-04
Q3 2019 $250K Sep 30, 2019 10-Q 2019-11-05
Q2 2019 $250K Jun 30, 2019 10-Q 2019-07-31
Q1 2019 $235K Mar 31, 2019 10-Q 2019-05-07
Q4 2018 $159K Dec 31, 2018 10-K 2020-02-27
* An asterisk sign (*) next to the value indicates that the value is likely invalid.